A Phase I Trial of Recombinant Vaccinia Virus That Expresses DF3/MUC1 in Patients With Metastatic Adnocarcinoma of the Breast
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Breast cancer vaccine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 15 Feb 2017 Biomarkers information updated
- 15 Oct 2005 New trial record.